Daniel Cowell Overview

  • Investor Type
  • Angel
  • Investments
  • 1
  • Portfolio
  • 1

Daniel Cowell General Information

Description

Mr. Daniel Cowell is a Co-Founder and serves as the Chief Executive Officer and a Board Member at Psyomics. He is a Board Member of Sentinal Oncology. He served as Chief Operating Officer at Horizon Discovery. He co-founded Pharmorphix, a specialist CRO in the area of solid form, which grew market share rapidly and was subsequently acquired by Sigma Aldrich in 2006. Following the sale of Pharmorphix he founded Hypoxium, a client focused CRO providing pre-clinical oncology research which grew its revenue at over 75% each year. He was appointed COO of Horizon Discovery following Hypoxium's acquisition in 2010. He holds a BS in Chemistry from University of Kent. He has spent the past 18 years leading the commercial and scientific direction of various UK based biotechnology companies, in fields ranging from oncology to translational genomics research.

Contact Information

Primary Investor Type
Angel (individual)

Daniel Cowell Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000000 10-Nov-2014 0000 00000 00.000 Database Software Generating Revenue 000000 000000
To view Daniel Cowell’s complete investments history, request access »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Daniel Cowell Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Daniel Cowell Team (1)

Name Title Deals Funds Boards Office
Daniel Cowell Angel Investor 0 0 London, United Kingdom
To view Daniel Cowell’s complete team members history, request access »